A Randomized Controlled Trial of Stereotactic Body Radiation Therapy Versus Chemoradiation Following Induction Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
OncologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Journal of gastrointestinal cancer
- Publicado em
- 27 out 2025
- Citações
- 2
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
A Randomized Controlled Trial of Stereotactic Body Radiation Therapy Versus Chemoradiation Following Induction Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
Vandana Thakur, Divya Khosla, Gaganpreet Singh, Rakesh Kapoor, Rajesh Gupta, Mahendra Kumar, Divyesh Kumar, Surinder S Rana, Harjeet Singh, Jimil Shah et al.
Descritores MeSH
- Pancreatic Neoplasms
- Adenocarcinoma
- Radiosurgery
- Chemoradiotherapy
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Gemcitabine
- Female
- Adult
- Deoxycytidine
Veja também
Estudos relacionados
- Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial
- Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial
- Chemotherapy and radiotherapy for advanced pancreatic cancer
- SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)